Aug 04, 2022
Pharming Group reports financial results for the first half of 2022
Aug 02, 2022
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
Aug 01, 2022
Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS
Jul 25, 2022
Pharming Group Notice of H1 2022 Results
Jun 02, 2022
Pharming Group to present at Jefferies Healthcare Conference 2022
May 18, 2022
Pharming Group: all proposals Annual General Meeting of Shareholders approved
May 12, 2022
Pharming Group reports financial results for the first quarter of 2022
May 05, 2022
Pharming Group Notice of Q1 2022 Results
Apr 26, 2022
Pharming receives agreement of Paediatric Investigation Plan and Promising Innovative Medicine designation for leniolisib from UK MHRA
Apr 01, 2022
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting
Displaying 1 - 10 of 12